Reticulocytopenia

From WikiMD's WELLNESSPEDIA

(Redirected from Aplastic crisis)


Reticulocytopenia
Synonyms
Pronounce N/A
Specialty N/A
Symptoms Low reticulocyte count
Complications Anemia, fatigue, pallor
Onset
Duration
Types N/A
Causes Bone marrow failure, aplastic anemia, chemotherapy, radiation therapy, vitamin deficiency
Risks
Diagnosis Complete blood count, reticulocyte count
Differential diagnosis Reticulocytosis, hemolytic anemia
Prevention
Treatment Address underlying cause, blood transfusion
Medication
Prognosis Depends on underlying cause
Frequency
Deaths N/A


Reticulocytopenia is a medical condition characterized by an abnormally low number of reticulocytes in the blood. Reticulocytes are immature red blood cells (RBCs) that are typically released from the bone marrow into the bloodstream, where they mature into fully functional RBCs. The condition is often indicative of underlying issues with erythropoiesis, the process by which new red blood cells are produced.

Causes[edit]

Reticulocytopenia can result from various conditions that affect the bone marrow's ability to produce reticulocytes. Some common causes include:

Symptoms[edit]

The symptoms of reticulocytopenia are often related to the underlying cause and the resultant anemia. Common symptoms include:

Diagnosis[edit]

Diagnosis of reticulocytopenia typically involves a combination of blood tests and bone marrow examinations. Key diagnostic tests include:

Treatment[edit]

Treatment of reticulocytopenia focuses on addressing the underlying cause. Depending on the cause, treatment options may include:

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.